[177Lu]Lu-CHX-A″-DTPA-7F5

N/A

Report date: 2025/10/30 16:14:28

Base Information

Drug Name[177Lu]Lu-CHX-A″-DTPA-7F5
Drug Alias Name[177Lu]Lu-CHX-A″-DTPA-7F5177Lu-CHX-A″-DTPA-7F5
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Radioactive therapeutic agent +[6] 
Mechanisms of ActionAnti-PSCA
TargetsProstate stem cell antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTechnical University DresdenHelmholtz-Zentrum Dresden-Rossendorf
China Registration ClassN/A

Develop Information

Active CompaniesTechnical University DresdenHelmholtz-Zentrum Dresden-Rossendorf
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A